REGENXBIO INC's ticker is RGNX and the CUSIP is 75901B107. A total of 186 filers reported holding REGENXBIO INC in Q1 2022. The put-call ratio across all filers is 0.84 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $601,152 | -18.1% | 36,522 | -0.6% | 0.09% | -8.4% |
| Q2 2023 | $734,253 | +31.7% | 36,731 | +24.6% | 0.10% | +25.0% |
| Q1 2023 | $557,467 | -14.8% | 29,480 | +2.2% | 0.08% | -19.1% |
| Q4 2022 | $654,409 | -15.9% | 28,854 | -1.9% | 0.09% | -26.6% |
| Q3 2022 | $778,000 | -27.8% | 29,418 | +6.1% | 0.13% | -30.1% |
| Q2 2022 | $1,077,000 | +8.9% | 27,727 | -7.0% | 0.18% | +22.0% |
| Q1 2022 | $989,000 | +2.5% | 29,800 | +0.9% | 0.15% | +3.4% |
| Q4 2021 | $965,000 | -19.2% | 29,523 | +3.6% | 0.14% | -28.9% |
| Q3 2021 | $1,195,000 | +11.0% | 28,507 | +2.8% | 0.20% | +12.1% |
| Q2 2021 | $1,077,000 | +21.3% | 27,727 | +6.6% | 0.18% | +15.2% |
| Q1 2021 | $888,000 | -26.9% | 26,019 | -2.9% | 0.16% | -30.7% |
| Q4 2020 | $1,215,000 | +65.1% | 26,786 | +0.1% | 0.23% | +51.0% |
| Q3 2020 | $736,000 | +1.4% | 26,749 | +35.7% | 0.15% | -7.4% |
| Q2 2020 | $726,000 | +10.7% | 19,705 | -2.7% | 0.16% | -3.6% |
| Q1 2020 | $656,000 | -23.7% | 20,255 | -3.5% | 0.17% | -9.1% |
| Q4 2019 | $860,000 | – | 20,995 | – | 0.19% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 1,167,684 | $28,842,000 | 9.84% |
| Sonic Fund II, L.P. | 193,079 | $4,769,000 | 2.91% |
| ArchPoint Investors | 253,181 | $6,254,000 | 2.48% |
| Redmile Group, LLC | 2,004,663 | $49,515,000 | 1.89% |
| Sofinnova Investments, Inc. | 776,624 | $19,183,000 | 1.60% |
| RTW INVESTMENTS, LP | 1,845,366 | $45,581,000 | 1.18% |
| WS MANAGEMENT LLLP | 416,997 | $10,300,000 | 0.84% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 104,129 | $2,572,000 | 0.79% |
| HARBOR CAPITAL ADVISORS, INC. | 30,251 | $747,000 | 0.57% |
| Atom Investors LP | 36,487 | $901,000 | 0.39% |